Subpart G. Subpart G—Tumor Associated Antigen immunological Test Systems

• § 866.6000 - Whole exome sequencing constituent device.
• § 866.6010 - Tumor-associated antigen immunological test system.
• § 866.6020 - Immunomagnetic circulating cancer cell selection and enumeration system.
• § 866.6030 - AFP-L3% immunological test system.
• § 866.6040 - Gene expression profiling test system for breast cancer prognosis.
• § 866.6050 - Ovarian adnexal mass assessment score test system.
• § 866.6060 - BCR-ABL quantitation test.
• § 866.6080 - Next generation sequencing based tumor profiling test.
• § 866.6100 - DNA-based test to measure minimal residual disease in hematological malignancies.